← All trials
NCT06040372
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 16, 2020
- Primary completion
- Mar 30, 2022
- Completion date
- Jul 30, 2022
- First posted
- Sep 15, 2023
- Last posted
- Sep 15, 2023
- Enrollment
- 112
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- LGLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.